Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CKM and LILRB5 are associated with serum levels of creatine kinase.
Dubé MP, Zetler R, Barhdadi A, Brown AM, Mongrain I, Normand V, Laplante N, Asselin G, Zada YF, Provost S, Bergeron J, Kouz S, Dufour R, Diaz A, de Denus S, Turgeon J, Rhéaume E, Phillips MS, Tardif JC. Dubé MP, et al. Among authors: turgeon j. Circ Cardiovasc Genet. 2014 Dec;7(6):880-6. doi: 10.1161/CIRCGENETICS.113.000395. Epub 2014 Sep 11. Circ Cardiovasc Genet. 2014. PMID: 25214527
Validation of warfarin pharmacogenetic algorithms in clinical practice.
Marin-Leblanc M, Perreault S, Bahroun I, Lapointe M, Mongrain I, Provost S, Turgeon J, Talajic M, Brugada R, Phillips M, Tardif JC, Dubé MP. Marin-Leblanc M, et al. Among authors: turgeon j. Pharmacogenomics. 2012 Jan;13(1):21-9. doi: 10.2217/pgs.11.120. Pharmacogenomics. 2012. PMID: 22176621
Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.
Perreault S, Shahabi P, Côté R, Dumas S, Rouleau-Mailloux É, Feroz Zada Y, Provost S, Mongrain I, Dorais M, Huynh T, Kouz S, Diaz A, Blostein M, de Denus S, Turgeon J, Ginsberg J, Lelorier J, Lalonde L, Busque L, Kassis J, Talajic M, Tardif JC, Dubé MP. Perreault S, et al. Among authors: turgeon j. Clin Cardiol. 2018 May;41(5):576-585. doi: 10.1002/clc.22948. Epub 2018 May 15. Clin Cardiol. 2018. PMID: 29542828 Free PMC article.
A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure.
de Denus S, Dubé MP, Fouodjio R, Huynh T, LeBlanc MH, Lepage S, Sheppard R, Giannetti N, Lavoie J, Mansour A, Provost S, Normand V, Mongrain I, Langlois M, O'Meara E, Ducharme A, Racine N, Guertin MC, Turgeon J, Phillips MS, Rouleau JL, Tardif JC, White M; CANDIID II investigators. de Denus S, et al. Among authors: turgeon j. Pharmacogenomics. 2018 May;19(7):599-612. doi: 10.2217/pgs-2018-0004. Epub 2018 Apr 27. Pharmacogenomics. 2018. PMID: 29701105 Clinical Trial.
Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure.
Kassem I, Sanche S, Li J, Bonnefois G, Dubé MP, Rouleau JL, Tardif JC, White M, Turgeon J, Nekka F, de Denus S. Kassem I, et al. Among authors: turgeon j. Clin Transl Sci. 2021 Jan;14(1):194-203. doi: 10.1111/cts.12842. Epub 2020 Aug 28. Clin Transl Sci. 2021. PMID: 32702160 Free PMC article.
An evaluation of pharmacists' expectations towards pharmacogenomics.
de Denus S, Letarte N, Hurlimann T, Lambert JP, Lavoie A, Robb L, Sheehan NL, Turgeon J, Vadnais B. de Denus S, et al. Among authors: turgeon j. Pharmacogenomics. 2013 Jan;14(2):165-75. doi: 10.2217/pgs.12.197. Pharmacogenomics. 2013. PMID: 23327577
369 results